Multiple sclerosis (MS) is an autoimmune inflammatory condition that occurs when the body’s immune system damages the myelin sheaths that cover and protect nerve cells.
Symptoms of MS include loss of balance, numbness or tingling, and weakness. Around 2.8 million people
live with the condition worldwide.
While there is currently no cure for MS, there are treatments to help manage symptoms. Research indicates that early treatment of MS is linked to slower disability progression and less productivity loss than treating the condition at later stages.
Understanding more about how treating MS at different stages affects disability could improve treatment strategies for the condition and improve the quality of life among patients.